Standard Operating Procedure for Lifecycle Maintenance of Product Registrations
| Department | Regulatory Affairs |
| SOP No. | RA/2026/669 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 11/04/2026 |
| Effective Date | 11/04/2026 |
| Review Date | 11/04/2028 |
Purpose
This Standard Operating Procedure (SOP) provides a structured framework to effectively manage the lifecycle maintenance of product registrations, ensuring continued regulatory compliance throughout the product’s commercial lifespan. It aims to standardize the process for implementing post-approval changes, handling variations, and maintaining up-to-date documentation with regulatory authorities to minimize compliance risks and support timely approvals.
Scope
This SOP applies to all activities related to the lifecycle maintenance of product registrations including post-approval changes, variation submissions, and documentation updates for all dosage forms and products governed under applicable regulatory frameworks. It covers interaction with regulatory authorities, documentation control, and compliance monitoring within the Regulatory Affairs department. Activities outside product registration changes, such as new product registrations or clinical trial filings, are excluded.
Responsibilities
- Regulatory Affairs Specialists: Prepare, review, and submit post-approval change documentation and variation dossiers.
- Regulatory Affairs Manager: Oversee the lifecycle maintenance process, ensure timelines and compliance.
- Quality Assurance: Review and approve changes impacting product quality and compliance.
- Documentation Control: Manage document versioning, storage, and distribution related to registration dossiers.
- Cross-Functional Teams (e.g., Manufacturing, QC, Engineering): Provide necessary technical information and validation data to support submissions.
Accountability
The Regulatory Affairs Head is accountable for the implementation, compliance, periodic review, and continuous improvement of this SOP. This role is also responsible for escalation of critical compliance issues and ensuring the SOP’s effectiveness across all relevant departments.
Procedure
1. Preparation and Identification of Changes:
Identify potential post-approval changes or variations through regular review of regulatory requirements, manufacturing processes, product quality data, and market feedback. Document any proposed changes with a Change Request Form or similar documentation.
2. Assessment and Impact Analysis:
Conduct a thorough impact assessment involving cross-functional teams (Manufacturing, Quality Control, Engineering, etc.) to evaluate the regulatory impact, quality attributes, validation, and timelines associated with the proposed change. Determine if the change necessitates a regulatory submission, and categorize the change type according to local regulatory guidelines (e.g., minor, moderate, major variation).
3. Preparation of Submission Documents:
Compile all required documentation including amended product dossiers, validation reports, batch data, test certificates, and cover letters as per the specific regulatory authority’s requirements. Ensure all documentation complies with applicable standards, is complete, and reviewed for accuracy.
4. Internal Review and Approvals:
Circulate the submission package among Regulatory Affairs reviewers, Quality Assurance, and other relevant stakeholders for approval. Address any comments or corrective actions identified during the review phase promptly.
5. Submission to Regulatory Authorities:
Submit the approved variation dossier or change notification electronically or physically as per regulatory agency guidelines. Retain acknowledgment receipts and track submission using established internal tracking systems.
6. Post-submission Follow-up:
Monitor correspondence from regulatory authorities for queries or requests for additional information. Coordinate timely responses with supporting departments and update the dossier accordingly.
7. Implementation of Approved Changes:
Once approval is obtained, communicate the approved changes to all impacted departments. Update relevant SOPs, batch records, labels, product information leaflets, and other controlled documents to reflect the approved changes. Ensure product manufacturing and release adhere to updated specifications.
8. Documentation and Record Retention:
Maintain a complete, indexed filing system for all submission packages, correspondences, approvals, and impact assessments. Ensure retrieval of records is straightforward for audits or inspections in compliance with data integrity and GMP standards.
9. Periodic Review and Continuous Improvement:
Conduct periodic reviews of the lifecycle maintenance process effectiveness, SOP compliance, and identify opportunities for process enhancements. Update the SOP and related training as required.
This procedure ensures controlled, compliant management of product registration lifecycles, supports regulatory submissions with robust documentation, and maintains product supply integrity in line with regulatory obligations.
Abbreviations
- GMP – Good Manufacturing Practice
- QA – Quality Assurance
- RA – Regulatory Affairs
- QC – Quality Control
- SOP – Standard Operating Procedure
- CSR – Change Submission Request
- CTD – Common Technical Document
Documents
- Change Request Form (Annexure-1)
- Variation Dossier Checklist (Annexure-2)
- Regulatory Submission Tracking Log (Annexure-3)
References
- ICH Q12: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
- FDA Guidance for Industry: Post-Approval Manufacturing Changes to Approved Drug Products
- EU Guidelines on Variations to Marketing Authorisations
- Internal Quality Management System Documentation
- Good Manufacturing Practice (GMP) Guidelines
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Change Request Form
| Title | Change Request Form |
| Purpose | To document and initiate review of proposed post-approval changes affecting product registration. |
| Field | Entry |
|---|---|
| Change Request No. | CR-2026-045 |
| Date of Request | 05/04/2026 |
| Department Initiating Change | Manufacturing |
| Description of Change | Modification in packaging material supplier |
| Reason for Change | Supplier certification update |
| Impact on Registration | Requires Type II variation submission |
| Supporting Documentation | Supplier GMP Certificate, Validation Report |
| Requested By (Function) | Manufacturing Supervisor |
| Reviewed By (RA) | — |
| Approved By (QA) | — |
| Final Decision | Pending |
| Comments | — |
Annexure-2: Variation Dossier Checklist
| Title | Variation Dossier Checklist |
| Purpose | To ensure completeness and compliance of variation submission dossiers. |
| Checklist Item | Status | Comments |
|---|---|---|
| Cover Letter | Completed | Aligned with current guidelines |
| Revised Product Information | Completed | Updated with packaging supplier details |
| Validation Reports | Completed | Supplier change validation included |
| Risk Assessment | Completed | Confirms no adverse impact on quality |
| Supporting Certificates | Completed | GMP certificate attached |
| Submission Form | Completed | Signed and dated |
| Sign-Off by RA | Pending | Awaiting final review |
Annexure-3: Regulatory Submission Tracking Log
| Title | Regulatory Submission Tracking Log |
| Purpose | To track all regulatory submissions related to lifecycle maintenance activities. |
| Submission No. | Product | Type of Submission | Submission Date | Authority | Status | Approval Date | Comments |
|---|---|---|---|---|---|---|---|
| SUB-2026-101 | Product A | Type II Variation | 11/04/2026 | FDA | Under Review | — | Additional data requested |
| SUB-2026-102 | Product B | Minor Variation | 10/04/2026 | EMA | Approved | 20/04/2026 | — |
| SUB-2026-103 | Product C | Annual Update | 09/04/2026 | Health Canada | Approved | 18/04/2026 | — |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 11/04/2026 | 1.0 | Initial issue | New SOP creation |